In a recent study, researchers described the X-ray crystal structure of a complex of the Omicron RBD with broadly neutralizing sarbecovirus mAb S309...
2022
Hair growth and our immune system
In a recent paper, researchers have identified a potential target for treatment of alopecia, a autoimmune disorder whereby the immune system attacks the hair follicles resulting in hair loss...
SARS-CoV-2 – a weakness?
In a recent paper, researchers have identified and described an epitope capable of neutralising a variety of coronaviruses including SARS-CoV-1, WIV1 and SHC014...
The immune system and obesity
In a recent paper by Schmidt, et al., researchers have investigated the immunoregulatory effects of type 2 T helper (Th2) cells in an environment characterised by significantly high fat stores and malnutrition...
Adaptations of tissue-resident memory T cells
In a recent paper by Crowl, et al., researchers provide novel insights into CD8+ tissue-resident memory T cells, describing how these cells adapt when present within specific environments, differing from one another...
Using lipid nanoparticles for cancer treatment
In a recent paper, Zhang, et al, have developed nanoparticles that can break down the barriers around tumours, reaching cancerous cells, providing a potentially improved and effective treatment for cancers...
A vaccine with a dual threat to cancer
In a recent paper, Badrinath and colleagues report of a vaccine designed to target one tumour immune escape mechanism...
Can BCG vaccination reduce mortality and morbidity from COVID-19?
In a recent paper, researchers looked at the affects of BCG vaccination of COVID-19 mortality and morbidity...
A potential new vaccine for rabies
In a recent paper, Callaway, et al., identified and described a potential new and improved rabies vaccine design. A groundbreaking effort by researchers...
Does cancer immunoediting occur in humans?
In a recent paper, researchers investigated whether humans are capable of undergoing natural cancer immunoediting during the course of cancer progression...